What is Vera Therapeutics, Inc. Class A Common Stock's Market Cap?

Vera Therapeutics, Inc. Class A Common Stock's Market Cap is $2.4B, based on as-reported figures from SEC (XBRL) filings.

What is Vera Therapeutics, Inc. Class A Common Stock's Enterprise Value?

Vera Therapeutics, Inc. Class A Common Stock's Enterprise Value is $2.0B, based on as-reported figures from SEC (XBRL) filings.

What is Vera Therapeutics, Inc. Class A Common Stock's EV / EBITDA?

Vera Therapeutics, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Vera Therapeutics, Inc. Class A Common Stock's Net Income (TTM)?

Vera Therapeutics, Inc. Class A Common Stock's Net Income (TTM) is -$401.9M, based on as-reported figures from SEC (XBRL) filings.

What is Vera Therapeutics, Inc. Class A Common Stock's EBITDA?

Vera Therapeutics, Inc. Class A Common Stock's EBITDA is -$415.2M, based on as-reported figures from SEC (XBRL) filings.

What is Vera Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM)?

Vera Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM) is -5.58, based on as-reported figures from SEC (XBRL) filings.

What is Vera Therapeutics, Inc. Class A Common Stock's Net Debt?

Vera Therapeutics, Inc. Class A Common Stock's Net Debt is -$423.9M, based on as-reported figures from SEC (XBRL) filings.

Vera Therapeutics, Inc. Class A Common Stock (VERA) Financial Statements

Vera Therapeutics, Inc. Class A Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00Q72WYH2

XNAS · usd

33.78▼ 1.50 (-4.25%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close35.28

Day's Range33.75 – 35.48

52-Week Range22.72 – 56.05

Volume937.8K

Avg Volume1.9M

Share Statistics

Shares Outstanding

Employees249

ExchangeXNAS

Listed2021-05-14

Share count as of July 29, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Vera Therapeutics, Inc. Class A Common Stock (VERA)

What is Vera Therapeutics, Inc. Class A Common Stock's Market Cap?: Vera Therapeutics, Inc. Class A Common Stock's Market Cap is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is Vera Therapeutics, Inc. Class A Common Stock's Enterprise Value?: Vera Therapeutics, Inc. Class A Common Stock's Enterprise Value is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Vera Therapeutics, Inc. Class A Common Stock's EV / EBITDA?: Vera Therapeutics, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Vera Therapeutics, Inc. Class A Common Stock's Net Income (TTM)?: Vera Therapeutics, Inc. Class A Common Stock's Net Income (TTM) is -$401.9M, based on as-reported figures from SEC (XBRL) filings.
What is Vera Therapeutics, Inc. Class A Common Stock's EBITDA?: Vera Therapeutics, Inc. Class A Common Stock's EBITDA is -$415.2M, based on as-reported figures from SEC (XBRL) filings.
What is Vera Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM)?: Vera Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM) is -5.58, based on as-reported figures from SEC (XBRL) filings.
What is Vera Therapeutics, Inc. Class A Common Stock's Net Debt?: Vera Therapeutics, Inc. Class A Common Stock's Net Debt is -$423.9M, based on as-reported figures from SEC (XBRL) filings.